Integrated safety summary for trifluridine/tipiracil (TAS-102)

Falcone, A; Ohtsu, A; Van Cutsem, E; Mayer, RJ; Buscaglia, M; Bendell, JC; Kopetz, S; Bebeau, P; Yoshino, T

Falcone, A (reprint author), Univ Pisa, Pisana Univ Hosp, Via Roma 67, I-56126 Pisa, Italy.

ANTI-CANCER DRUGS, 2018; 29 (1): 89

Abstract

Trifluridine/tipiracil, an oral treatment combining trifluridine (an antineoplastic thymidine-based nucleoside analog) and tipiracil hydrochloride (a ......

Full Text Link